GFR estimated by CKD-EPI equations (NKF 2021). Recommend confirmation of eGFR using Cystatin C based eGFR in complex cases for clinical decision-making.
The testing method is an immunoassay manufactured by Beckman Coulter Inc performed on DxI/Access platform. Values obtained with different assay methods may be different and cannot be used interchangeably.
A1C Diagnostic Criteria:
Prediabetes: 5.7% - 6.4%
Diabetes: >=6.5%
A1C Glycemic Goals:
Older Adults: <7.0%
Children and Adolescents: <7.0%
Pregnant Women: <6.0%
A1C goals must be individualized and reassessed over time.
This test is performed on Capillarys 3 (Sebia, Inc) and is certified by the National Glycohemoglobin Standardization Program. This method is not affected by HbC, HbS, HbE or HbD trait or by HbF <23.0%.
Reference: Standards of Medical Care in Diabetes. Diabetes Care, 43(1), S1-S212, 2020.